Respiratory Syncytial Virus (RSV) is a common and potentially severe infection in newborns, affecting the respiratory tract. At the Newborn Care Centre (NBCC) in Rajendra Nagar, Patna, Dr. Shrawan Kumar specializes in monitoring and providing advanced care for newborns at risk of or suffering from RSV infection. His preventive and treatment approaches, including the use of monoclonal antibodies, are designed to safeguard vulnerable infants.
RSV infections can cause mild cold-like symptoms, but in newborns—particularly preterm infants or those with weakened immune systems—it may lead to severe conditions like bronchiolitis or pneumonia. Dr. Kumar begins by closely observing newborns with symptoms such as coughing, wheezing, or difficulty breathing. Diagnostic tests, including nasal swabs and chest X-rays, are used to confirm the presence of RSV and assess the severity of the infection.
Treatment at NBCC focuses on supportive care, such as ensuring the baby receives adequate oxygen and maintaining hydration. For mild cases, Dr. Kumar provides guidance on home care, but severe cases are managed in the hospital, where oxygen therapy, nebulization, and other interventions are used under his supervision. Dr. Kumar’s expertise ensures the timely detection and management of complications.
To prevent RSV in high-risk infants, Dr. Kumar advocates the use of monoclonal antibodies, such as Palivizumab. This preventive therapy provides passive immunity, reducing the likelihood of severe RSV infections. Administered as monthly injections during RSV season, it is especially beneficial for preterm infants and those with chronic lung or heart conditions. Dr. Kumar educates parents about this preventive measure, ensuring they understand its importance and schedule.
Under Dr. Shrawan Kumar’s observation at NBCC, RSV infections are managed with precision, and high-risk infants are protected through cutting-edge preventive strategies, including monoclonal antibodies. His dedication ensures better health outcomes for newborns.